Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy.
Publication
, Conference
Downie, BJ; Erba, HP; Stone, RM; Rizzieri, DA; Foran, JM
Published in: Blood
November 20, 2009
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 20, 2009
Volume
114
Issue
22
Start / End Page
2076 / 2076
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Downie, B. J., Erba, H. P., Stone, R. M., Rizzieri, D. A., & Foran, J. M. (2009). Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy. In Blood (Vol. 114, pp. 2076–2076). American Society of Hematology. https://doi.org/10.1182/blood.v114.22.2076.2076
Downie, Ben J., Harry P. Erba, Richard M. Stone, David A. Rizzieri, and James M. Foran. “Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy.” In Blood, 114:2076–2076. American Society of Hematology, 2009. https://doi.org/10.1182/blood.v114.22.2076.2076.
Downie BJ, Erba HP, Stone RM, Rizzieri DA, Foran JM. Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy. In: Blood. American Society of Hematology; 2009. p. 2076–2076.
Downie, Ben J., et al. “Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy.” Blood, vol. 114, no. 22, American Society of Hematology, 2009, pp. 2076–2076. Crossref, doi:10.1182/blood.v114.22.2076.2076.
Downie BJ, Erba HP, Stone RM, Rizzieri DA, Foran JM. Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy. Blood. American Society of Hematology; 2009. p. 2076–2076.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 20, 2009
Volume
114
Issue
22
Start / End Page
2076 / 2076
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology